NCT04977882

Brief Summary

Monocentric, two-level factorial, parallel-arm, pilot randomized clinical trial, conducted comparing patients undergoing laparoscopic right hemicolectomy with ICA for right colon cancer in a single unit of a teaching hospital: Minimally Invasive Surgery Unit, Department of Surgical Sciences, Policlinico Tor Vergata, Rome, Italy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Oct 2020

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.8 years

First QC Date

July 15, 2021

Last Update Submit

November 20, 2023

Conditions

Keywords

intracorporeal anastomosisright hemicoletomycolon cancer

Outcome Measures

Primary Outcomes (1)

  • Tolerance to solid diet

    time to light diet tolerance

    30 days postoperatively

Secondary Outcomes (12)

  • White blood cell

    30 days postoperatively

  • Procalcitonine

    30 days postoperatively

  • Days of hospitalization

    90 days postoperatively

  • Readmission rate

    90 days postoperatively

  • Mortality rate

    90 days postoperatively

  • +7 more secondary outcomes

Study Arms (3)

Abdominal drainage

EXPERIMENTAL

19 Fr abdominal drainage placed intraoperatevely in right paracolic gutter

Procedure: abdominal drainageProcedure: Laparoscopic radical right colectomy with CME and D3 lymphadenectomy (RRC)Procedure: Laparoscopic standard D2 right hemicolectomy (STANDARD)

Postoperative antibiotico-prophylaxis

EXPERIMENTAL

postoperative antibiotico-prophylaxis with Ceftriaxone 2gr and Metronidazole 1.5gr

Drug: Postoperative antibiotico-prophylaxisProcedure: Laparoscopic radical right colectomy with CME and D3 lymphadenectomy (RRC)Procedure: Laparoscopic standard D2 right hemicolectomy (STANDARD)

Control group

SHAM COMPARATOR

No drainage nor postoperative antibiotico-prophylaxis

Procedure: Laparoscopic radical right colectomy with CME and D3 lymphadenectomy (RRC)Procedure: Laparoscopic standard D2 right hemicolectomy (STANDARD)

Interventions

19 Fr abdominal drainage placed intraoperatively in right colic gutter

Abdominal drainage

Ceftriaxone 2 gr and Metronidazole 1.5 gr per day for 2 days postoperatively

Postoperative antibiotico-prophylaxis

the dissection starts over the landmark given by SMV. The SMV is freed anteriorly and on its right-hand side from all the lympho-adipose tissue. Once the SMV is fully exposed, the IC vessels are dissected and divided at the junction with the efferent vessels. The dissection moves upward along the same dissection line to identify the right colic vein and the GCTH. No medial to later dissection is carried out until the SMV is completely exposed before reaching the uncinate process of the pancreas. At this point the veins to the right colon are divided but gastroepiploic vein and artery are preserved unless the tumor is located at the hepatic flexure. The divided mesentery is lifted and tilted to the right, and the medial-to-later dissection starts following the embryological plane over Fredet's fascia. The mesocolon is divided on the right side of the middle colic artery and the right branches of the middle colic vessels are divided.

Abdominal drainageControl groupPostoperative antibiotico-prophylaxis

A medial-to-lateral surgical dissection and high tie of the ileocolic vessels (IC) is undertaken without dissecting the anterior surface of the superior mesenteric vein (SMV). The gastro-colic trunk of Henle (GCTH) is not isolated and the right colic vein (when present) and the right branches of the middle colic vessels are taken more peripherical, during the division of the transverse mesocolon. The right gastroepiploic vessels are not dissected, nor divided, unless in proximity of the tumor

Abdominal drainageControl groupPostoperative antibiotico-prophylaxis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Right colon cancer
  • Intracorporeal anastomosis
  • Laparoscopic surgery
  • Elective surgery
  • informed consent signed

You may not qualify if:

  • below 18 years old
  • IBD
  • ASA IV
  • T4b
  • Metastatic disease
  • Preoperative steroids
  • Conversion to open surgery
  • Emergency surgery
  • concomitant major operation
  • preoperative infective status
  • benign disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rome Tor Vergata

Rome, 00133, Italy

Location

Related Publications (1)

  • Sica GS, Siragusa L, Pirozzi BM, Sorge R, Baldini G, Fiorani C, Guida AM, Bellato V, Franceschilli M. Gastrointestinal functions after laparoscopic right colectomy with intracorporeal anastomosis: a pilot randomized clinical trial on effects of abdominal drain, prolonged antibiotic prophylaxis, and D3 lymphadenectomy with complete mesocolic excision. Int J Colorectal Dis. 2024 Jul 6;39(1):102. doi: 10.1007/s00384-024-04657-0.

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: Patients were initially randomized for postoperative management into three arms to receive prolonged antibiotic prophylaxis (ABX group), abdominal drain placement (DRAIN group) or neither (NONE group) (I level randomization). The same patients were further randomized for surgical technique in two arms to receive RRC (RRC group) or standard hemicolectomy with D2 dissection (STANDARD group) (II level of randomization).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Minimally Invasive Surgery Unit

Study Record Dates

First Submitted

July 15, 2021

First Posted

July 27, 2021

Study Start

October 1, 2020

Primary Completion

August 1, 2022

Study Completion

August 1, 2023

Last Updated

November 22, 2023

Record last verified: 2023-11

Locations